The Global Pharmaceutical Isolator Market 2020, according to MRFR, is poised to grow at a CAGR of 7.86% to acquire USD 32.94 billion till 2023.
The primary driver of the market is the explosive growth of the pharmaceutical industry. In the drug producing pipeline, pharmaceutical insulators are imperative by segregating drugs from people. The high utilisation of these systems in filling lines is expected to boost market demand over the projected period. The introduction and addition of new products using pharmaceutical insulators is another factor contributing to the growth of the global market for pharmaceutical insulators. Furthermore, the increasing use of aseptic methods, increasing numbers of research laboratories, non-compliance costs, increasing use of hazardous materials and advances in isolator efficiency are some of the factors fueling the growth of the global pharmaceutical isolators market.
Request Sample Copy:
Other factors that can stimulate the growth of the pharmaceutical insulator market are the decontamination of aseptic systems, mixing of toxic compounds and multi-product manufacturing tasks of pharmaceutical companies. Strict government policies regarding employee safety are likely to influence major drug manufacturers’ purchasing decisions in the years ahead. Another factor that can lead to its integration in modern setups is the low operating costs of these systems on the manufacturing process. Increasing demand for devices or systems that can guarantee the potency and effectiveness of drugs can have a positive effect on the market.
The global pharmaceutical insulator market was segmented into closed systems and open systems, based on type. The leading segment is Open Isolator and is expected to hit USD 20.56 billion by the end of 2023.
By pressure, the global market for pharmaceutical insulators has been segmented into positive pressure insulators and negative pressure isolators. During the forecast period, the positive pressure segment holds a significant market share with the CAGR 8.42 per cent.
The global market for pharmaceutical insulators was separated by application into sampling/ weighing/ distribution isolators, aseptic insulators, containment insulators, fluid dispensing isolators and others. Due to the associated benefits such as protecting the operator from drug exposure, eliminating the chance of cross-contamination and maintaining the product’s quality standard, the fluid dispensing segment is expected to show the highest CAGR 9.92 per cent during the forecast period.
The global market is analyzed primarily as the Americas, Asia-Pacific, Europe, and Middle East & Africa.
The Americas is likely to dominate the global market for pharmaceutical insulators with a market share of 36.4 percent due to the increasing adoption of new technology, high healthcare expenditure, and the growing number of biotechnology laboratories and healthcare providers.
Due to the presence of a strong and well-established pharmaceutical industry, Europe holds the second-largest market share in Western Europe.
In the forecast period, Asia-Pacific region expected to record the highest CAGR of 8.73 per cent. It occupies the third most important position on the market for Pharmaceutical Isolator.
Middle East & Africa is expected to see limited growth due to undeveloped pharmaceutical and healthcare sectors and inadequate facilities for research and development.
The eminent players in the global pharmaceutical isolator market are COMECER SpA cf. p.iva, Skan AGGetinge AB, Hosokawa Micron Ltd, Azbil Telstar, VanRx Pharmasystems Inc., NuAire Inc., Schematic Engineering Industries, MBRAUN, Robert Bosch GmbH, Fedegari Autoclavi SpA, LAF Technologies Pty Ltd., IsoTech Design, Gelman Singapore Pte Ltd.
Browse Full Report @
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.